Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0042849 COMPOSITION FOR BRAIN IMPROVEMENT
The invention relates to the use of glutamine, preferably in the form of free amino acids, dipeptides and/or tripeptides, in the manufacture of a nutritional...
2017/0042848 BIOFILM INHIBITING COMPOSITIONS ENHANCING WEIGHT GAIN IN LIVESTOCK
A method of enhancing the growth of an anima, as well as treating or preventing antimicrobial infections is provided. The method includes causing the animal to...
2017/0042847 METHOD TO DELIVER ANTIFIBRINOLYTIC DRUGS TO MITIGATE DAMAGE TO THE BRAIN CAUSED BY CONCUSSIVE IMPACT
Antifibrinolytic agents/drugs are applied to the concussive area of a patient's brain to counter the activation of a fibrinolytic process in the concussive...
2017/0042846 METHOD OF MAKING WOUND GEL CONTAINING ANTIMICROBIAL COMPOSITION
A gel useful in reducing bacterial colonization in or around the area of a wound can be provided from at least one PEG and an aqueous composition having a pH...
2017/0042845 ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The ...
2017/0042844 BENZOIC ACID COMPOUNDS FOR REDUCING URIC ACID
Uric acid in mammalian subjects is reduced and excretion of uric acid is increased by administering a compound of Formula I. The uric acid-lowering effects of...
2017/0042843 COMPOSITIONS AND METHODS FOR INHIBITING INTIMAL HYPERPLASIA
Methods are provided for preventing, inhibiting, or treating intimal hyperplasia in a patient who has undergone a coronary bypass procedure that include...
2017/0042842 Sensorineural Hair Cell Differentiation
The present disclosure provides compositions and methods for treating subjects at risk for or with sensorineural hearing loss. Such compositions and methods...
2017/0042841 COMPOSITIONS FOR USE IN SURGERY
A method is provided for treating a subject in need of medication as an adjunct to elective surgery, comprising administration of a ketogenic material...
2017/0042840 USE OF 1,3-PROPANEDISULFONIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR THE TREATMENT OF SARCOIDOSIS
The present disclosure relates to methods for the treatment of sarcoidosis. In certain aspects and embodiments, the disclosure provides compositions containing...
2017/0042839 ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in...
2017/0042838 Treatment of Fibrosis
The present invention relates an aldehyde dehydrogenase inhibitor for use in the treatment or prevention of fibrosis.
2017/0042837 CAPSULE DOSAGE FORM OF METOPROLOL SUCCINATE
This disclosure provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, wherein said capsule dosage form...
2017/0042836 Treatment of Irritable Bowel Syndrome
A method of treating irritable bowel syndrome in a patient in need thereof by administering to said patient a pharmaceutically effective amount of tapentadol.
2017/0042835 PHARMACEUTICAL COMPOSITIONS COMPRISING HEMP AND TURMERIC TO TREAT PAIN AND INFLAMMATION
The present invention comprises compositions comprising therapeutically effective amounts of CBD and curcumin in various combinations to treat pain. CBD and...
2017/0042834 ION CHANNEL ACTIVATORS AND METHODS OF USE
The present invention relates to compositions of ion channel activators and methods of preparation, formulation, and the medical use of these compositions. In...
2017/0042833 Formulation of Curcuminoids with Enhanced Bioavailability of Curcumin, Demethoxycurcumin, Bisdemethoxycurcumin...
A formulation of curcuminoid mixture having curcumin, demethoxycurcumin and bisdemethoxycurcumin and an essential oil of turmeric having 45% Ar-turmerone. The...
2017/0042832 CB2 RECEPTOR LIGANDS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
The present invention provides cannabinoid type 2 (CB2) receptor inverse agonists for treating or ameliorating psychiatric disorders. The present invention...
2017/0042831 METHOD AND COMPOSITION FOR ENHANCING MILK PRODUCTION
The present invention concerns a method of enhancing milk production by a ruminant that includes providing a feed that contains sorbitol and at least one...
2017/0042830 FILM DELIVERY SYSTEM FOR ACTIVE INGREDIENTS
The present invention includes a pharmaceutical-based film system which includes various small-scale forms of pharmaceutically active agents, including...
2017/0042829 METHODS OF PREPARING POLYELECTROLYTE COMPLEX NANOPARTICLES
The presently disclosed subject matter provides methods for continuously generating uniform polyelectrolyte complex (PEC) nanoparticles comprising: flowing a...
2017/0042828 THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME
The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid, a basic therapeutic agent having a protonatable...
2017/0042827 PROTEINOID COMPOUNDS, PROCESS OF PREPARING SAME AND USES THEREOF
Proteinoid compounds characterized by a molecular weight (Mw) of at least 15,000 Da, processes of preparing such compounds and methods of use thereof, are...
2017/0042826 NANOLIPIDIC PARTICLE ASSEMBLY POPULATIONS
Nanolipidic Particles (NLPs) having average mean diameters of 1 nm to 20 nm are made from a precursor solution. NLPs can be loaded with a desired passenger...
2017/0042825 LIPID NANO PARTICLES COMPRISING CATIONIC LIPID FOR DRUG DELIVERY SYSTEM
The present invention provides a lipid nano-particles, which allow nucleic acids to be easily introduced into cells, comprising a cationic lipid represented by...
2017/0042824 GM3 FUNCTIONALIZED NANOPARTICLES
Embodiments disclosed herein relates to ganglioside GM3-containing mixed lipids nanoparticles having an overall size between 60-100 nm, the making thereof and...
2017/0042823 CO-ENCAPSULATION OF ANTIMICROBIALS AND ADJUVANTS IN NANOCARRIERS
Microbial infections have become increasingly difficult to treat due to the emergence of drug resistant microbes. Adjunctive therapies can be used to better...
2017/0042822 NON-STICKY NANOFIBROUS MEMBRANE HAVING CORE AND SHELL AND PROCESS OF PRODUCING SAME
A process of producing a non-sticky nanofibrous membrane includes pouring dimethylformamide (DMF) and dichloromethane into a first flask; pouring about 1 to...
2017/0042821 COMBINATION TABLET WITH CHEWABLE OUTER LAYER
A pharmaceutical composition in the form of a combination tablet is described. The tablet has a rapidly absorbed component that enters the circulation by...
2017/0042820 Calcium Alginate Dosage Formulations, and Methods of Making and Using Thereof
An alginate and stearic acid composition is described, including methods of molding it into tablets further comprising a drug, and methods of controlling the...
2017/0042819 NANOPARTICLES FOR TARGETED GENE THERAPY AND METHODS OF USE THEREOF
The present disclosure provides targeted, polymeric nanoparticles which facilitate the delivery of small interfering RNAs, miRNAs and shRNA expressing plasmid...
2017/0042818 LUNG TARGETING DUAL DRUG DELIVERY SYSTEM
The American Cancer Society estimated that in 2009, 1,479,350 new cancer cases would be diagnosed in the United States of which 219,440 would be lung and...
2017/0042817 METHOD AND SYSTEM FOR PRODUCING HIGH PURITY VANCOMYCIN HYDROCHLORIDE
A method is provided for preparing spray dried powder containing vancomycin hydrochloride. The method comprises providing a vancomycin hydrochloride solution...
2017/0042816 DELIVERY OF BIOLOGIC THERAPEUTICS
Formulations and methods are disclosed which provide controlled, sustained release of a biologic therapeutic to a space within the body. More specifically,...
2017/0042815 Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer...
In one embodiment, the present application discloses synthetic LDL nanoparticles comprising mixtures of components selected from the group consisting of...
2017/0042814 NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
The present invention provides novel, stable lipid particles comprising one or more active agents or therapeutic agents, methods of making the lipid particles,...
2017/0042813 LIPOSOME COMPOSITION AND METHOD FOR PRODUCING SAME
Provided are a liposome composition in which an osmotic pressure of an inner water phase is 2-fold to 8-fold relative to the osmotic pressure of an outer water...
2017/0042812 METHOD FOR PRODUCING LIPOSOME
Provided is a method for producing a liposome having safety and stability. According to the present invention, it is possible to provide a method for producing...
2017/0042811 LIPOSOME COMPOSITION AND METHOD FOR PRODUCING SAME
Provided are a liposome composition which has a practically required long-term preservation stability, and which has a release rate of a drug on the order of...
2017/0042810 LIPOSOME COMPOSITION AND METHOD FOR PRODUCING SAME
Provided are a liposome composition which has a practically required long-term preservation stability, and which has a release rate of a drug on the order of...
2017/0042809 STABLE LIPOSOMAL FORMULATIONS OF CARBONIC ANHYDRASE INHIBITORS FOR OCULAR DRUG DELIVERY
A stable liposomal formulation for ocular delivery of a carbonic anhydrase inhibitor. The formulation contains (i) a liposome that includes a lipid bilayer...
2017/0042808 EMULSION COMPOSITION
Provided is an emulsion composition that allows a lipophilic ingredient to have high stability and high in vivo absorbability. The emulsion composition includes...
2017/0042807 LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron....
2017/0042806 ORALLY DISINTEGRATING COMPOSITIONS
An orally disintegrating dosage form of a proton pump inhibitor, methods for its production and use thereof are provided. The dosage form includes a plurality...
2017/0042805 PET-MEDICINE-CAPSULE WRAPPER APPARATUS AND METHOD
Methods and compositions for obscuring medicines formed as tablets, capsules, pills, and so forth may be presented in clean packaging, with built-in work space...
2017/0042804 Polymer-Based Serum Albumin Substitute
This invention provides the use of a polymer comprising a hyperbranched polyether polyol such as hyperbranched polyglycerol as a serum albumin substitute. Also...
2017/0042803 USE OF A NOVEL NATURAL AGENT IN COSMETIC COMPOSITIONS
The invention is directed to methods of treating dermatological conditions, including cosmetic treatments intended to moisturize the epidermis, improve the...
2017/0042802 COSMETIC USE OF ARTEMIA SALINA EXTRACT TO PROTECT SKIN FROM THERMAL STRESS
Methods of protecting skin from damage due to cold thermal stress are disclosed. The methods include topically applying a composition that includes an Artemia...
2017/0042801 SKIN CREAM COMPOSITIONS
The invention provides a skin cream comprising: about 0.5 to 15% of colostrum; about 0.5 to 15% of a polyacrylamide based emulsifier; about 1.0 to 20% of an...
2017/0042800 USE OF UNDARIA EXTRACT TO REDUCE SIGNS OF SKIN AGING
Compositions for reducing skin aging are disclosed herein. The compositions can be topically applied to a skin region to reduce or prevent skin wrinkles, fine...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.